Literature DB >> 21622571

NF-κB essential modulator (NEMO) interaction with linear and lys-63 ubiquitin chains contributes to NF-κB activation.

Kamyar Hadian1, Richard A Griesbach, Scarlett Dornauer, Tim M Wanger, Daniel Nagel, Moritz Metlitzky, Wolfgang Beisker, Marc Schmidt-Supprian, Daniel Krappmann.   

Abstract

The IκB kinase (IKK) complex acts as a gatekeeper of canonical NF-κB signaling in response to upstream stimulation. IKK activation requires sensing of ubiquitin chains by the essential IKK regulatory subunit IKKγ/NEMO. However, it has remained enigmatic whether NEMO binding to Lys-63-linked or linear ubiquitin chains is critical for triggering IKK activation. We show here that the NEMO C terminus, comprising the ubiquitin binding region and a zinc finger, has a high preference for binding to linear ubiquitin chains. However, immobilization of NEMO, which may be reminiscent of cellular oligomerization, facilitates the interaction with Lys-63 ubiquitin chains. Moreover, selective mutations in NEMO that abolish association with linear ubiquitin but do not affect binding to Lys-63 ubiquitin are only partially compromising NF-κB signaling in response to TNFα stimulation in fibroblasts and T cells. In line with this, TNFα-triggered expression of NF-κB target genes and induction of apoptosis was partially compromised by NEMO mutations that selectively impair the binding to linear ubiquitin chains. Thus, in vivo NEMO interaction with linear and Lys-63 ubiquitin chains is required for optimal IKK activation, suggesting that both type of chains are cooperating in triggering canonical NF-κB signaling.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21622571      PMCID: PMC3138271          DOI: 10.1074/jbc.M111.233163

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction.

Authors:  Tobias L Haas; Christoph H Emmerich; Björn Gerlach; Anna C Schmukle; Stefanie M Cordier; Eva Rieser; Rebecca Feltham; James Vince; Uwe Warnken; Till Wenger; Ronald Koschny; David Komander; John Silke; Henning Walczak
Journal:  Mol Cell       Date:  2009-12-11       Impact factor: 17.970

2.  Crystal structure of the NEMO ubiquitin-binding domain in complex with Lys 63-linked di-ubiquitin.

Authors:  Azusa Yoshikawa; Yusuke Sato; Masami Yamashita; Hisatoshi Mimura; Atsushi Yamagata; Shuya Fukai
Journal:  FEBS Lett       Date:  2009-09-18       Impact factor: 4.124

3.  Two-sided ubiquitin binding explains specificity of the TAB2 NZF domain.

Authors:  Yogesh Kulathu; Masato Akutsu; Anja Bremm; Kay Hofmann; David Komander
Journal:  Nat Struct Mol Biol       Date:  2009-11-22       Impact factor: 15.369

4.  DARPin-assisted crystallography of the CC2-LZ domain of NEMO reveals a coupling between dimerization and ubiquitin binding.

Authors:  Olivera Grubisha; Monika Kaminska; Stéphane Duquerroy; Elisabeth Fontan; Florence Cordier; Ahmed Haouz; Bertrand Raynal; Jeanne Chiaravalli; Muriel Delepierre; Alain Israël; Michel Véron; Fabrice Agou
Journal:  J Mol Biol       Date:  2009-10-23       Impact factor: 5.469

5.  Critical role of PI3K signaling for NF-kappaB-dependent survival in a subset of activated B-cell-like diffuse large B-cell lymphoma cells.

Authors:  Bernhard Kloo; Daniel Nagel; Matthias Pfeifer; Michael Grau; Michael Düwel; Michelle Vincendeau; Bernd Dörken; Peter Lenz; Georg Lenz; Daniel Krappmann
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-20       Impact factor: 11.205

6.  c-IAP1 and UbcH5 promote K11-linked polyubiquitination of RIP1 in TNF signalling.

Authors:  Jasmin N Dynek; Tatiana Goncharov; Erin C Dueber; Anna V Fedorova; Anita Izrael-Tomasevic; Lilian Phu; Elizabeth Helgason; Wayne J Fairbrother; Kurt Deshayes; Donald S Kirkpatrick; Domagoj Vucic
Journal:  EMBO J       Date:  2010-11-26       Impact factor: 11.598

7.  NEMO specifically recognizes K63-linked poly-ubiquitin chains through a new bipartite ubiquitin-binding domain.

Authors:  E Laplantine; E Fontan; J Chiaravalli; T Lopez; G Lakisic; M Véron; F Agou; Alain Israël
Journal:  EMBO J       Date:  2009-09-17       Impact factor: 11.598

8.  Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains.

Authors:  David Komander; Francisca Reyes-Turcu; Julien D F Licchesi; Peter Odenwaelder; Keith D Wilkinson; David Barford
Journal:  EMBO Rep       Date:  2009-04-17       Impact factor: 8.807

9.  A ubiquitin replacement strategy in human cells reveals distinct mechanisms of IKK activation by TNFalpha and IL-1beta.

Authors:  Ming Xu; Brian Skaug; Wenwen Zeng; Zhijian J Chen
Journal:  Mol Cell       Date:  2009-10-23       Impact factor: 17.970

10.  Specific recognition of linear ubiquitin chains by NEMO is important for NF-kappaB activation.

Authors:  Simin Rahighi; Fumiyo Ikeda; Masato Kawasaki; Masato Akutsu; Nobuhiro Suzuki; Ryuichi Kato; Tobias Kensche; Tamami Uejima; Stuart Bloor; David Komander; Felix Randow; Soichi Wakatsuki; Ivan Dikic
Journal:  Cell       Date:  2009-03-20       Impact factor: 41.582

View more
  56 in total

1.  Arabidopsis ALIX is required for the endosomal localization of the deubiquitinating enzyme AMSH3.

Authors:  Kamila Kalinowska; Marie-Kristin Nagel; Kaija Goodman; Laura Cuyas; Franziska Anzenberger; Angela Alkofer; Javier Paz-Ares; Pascal Braun; Vicente Rubio; Marisa S Otegui; Erika Isono
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-31       Impact factor: 11.205

Review 2.  Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases.

Authors:  Junying Yuan; Palak Amin; Dimitry Ofengeim
Journal:  Nat Rev Neurosci       Date:  2019-01       Impact factor: 34.870

Review 3.  CYLD-mediated signaling and diseases.

Authors:  Bryan J Mathis; Yimu Lai; Chen Qu; Joseph S Janicki; Taixing Cui
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

4.  Analysis of nuclear factor-κB (NF-κB) essential modulator (NEMO) binding to linear and lysine-linked ubiquitin chains and its role in the activation of NF-κB.

Authors:  Tobias Kensche; Fuminori Tokunaga; Fumiyo Ikeda; Eiji Goto; Kazuhiro Iwai; Ivan Dikic
Journal:  J Biol Chem       Date:  2012-05-17       Impact factor: 5.157

5.  Molecular Determinants of Scaffold-induced Linear Ubiquitinylation of B Cell Lymphoma/Leukemia 10 (Bcl10) during T Cell Receptor and Oncogenic Caspase Recruitment Domain-containing Protein 11 (CARD11) Signaling.

Authors:  Yong-Kang Yang; Chao Yang; Waipan Chan; Zhaoquan Wang; Katelynn E Deibel; Joel L Pomerantz
Journal:  J Biol Chem       Date:  2016-10-24       Impact factor: 5.157

6.  Diversification of the structural determinants of fibroblast growth factor-heparin interactions: implications for binding specificity.

Authors:  Ruoyan Xu; Alessandro Ori; Timothy R Rudd; Katarzyna A Uniewicz; Yassir A Ahmed; Scott E Guimond; Mark A Skidmore; Giuliano Siligardi; Edwin A Yates; David G Fernig
Journal:  J Biol Chem       Date:  2012-09-27       Impact factor: 5.157

7.  Molluscum Contagiosum Virus MC159 Abrogates cIAP1-NEMO Interactions and Inhibits NEMO Polyubiquitination.

Authors:  Sunetra Biswas; Joanna L Shisler
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

Review 8.  Regulation of NF-κB by ubiquitination.

Authors:  Jueqi Chen; Zhijian J Chen
Journal:  Curr Opin Immunol       Date:  2013-01-08       Impact factor: 7.486

9.  Innate immune-directed NF-κB signaling requires site-specific NEMO ubiquitination.

Authors:  Janice C Jun; Sylvia Kertesy; Mark B Jones; Jill M Marinis; Brian A Cobb; Justine T Tigno-Aranjuez; Derek W Abbott
Journal:  Cell Rep       Date:  2013-07-18       Impact factor: 9.423

10.  Two-sided ubiquitin binding of NF-κB essential modulator (NEMO) zinc finger unveiled by a mutation associated with anhidrotic ectodermal dysplasia with immunodeficiency syndrome.

Authors:  Flora Ngadjeua; Jeanne Chiaravalli; François Traincard; Bertrand Raynal; Elisabeth Fontan; Fabrice Agou
Journal:  J Biol Chem       Date:  2013-10-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.